Literature DB >> 30478213

Stathmin Is Required for Normal Mouse Mammary Gland Development and Δ16HER2-Driven Tumorigenesis.

Gustavo Baldassarre1, Barbara Belletti1, Ilenia Segatto2, Mara De Marco Zompit2, Francesca Citron2, Sara D'Andrea2, Gian Luca Rampioni Vinciguerra2,3, Tiziana Perin4, Stefania Berton2, Giorgia Mungo2, Monica Schiappacassi2, Cristina Marchini5, Augusto Amici5, Andrea Vecchione3.   

Abstract

Postnatal development of the mammary gland relies on the maintenance of oriented cell division and apicobasal polarity, both of which are often deregulated in cancer. The microtubule (MT) network contributes to control these processes; however, very little is known about the impact of altered MT dynamics in the development of a complex organ and on the role played by MT-interacting proteins such as stathmin. In this study, we report that female stathmin knock-out (STM KO) mice are unable to nurse their litters due to frank impairment of mammary gland development. In mouse mammary epithelial cells, loss of stathmin compromised the trafficking of polarized proteins and the achievement of proper apicobasal polarity. In particular, prolactin receptor internalization and localization was altered in STM KO mammary epithelial cells, leading to decreased protein stability and downmodulation of the Prl/PrlR/STAT5 signaling pathway. Absence of stathmin induced alterations in mitotic spindle orientation, accumulation of mitotic defects, and apoptosis, overall contributing to tissue disorganization and further decreasing the expansion of the mammary epithelial compartment. Loss of stathmin in MMTV-Δ16HER2 transgenic mice decreased the incidence and increased the latency of these very aggressive mammary carcinomas. Collectively, these data identify the essential mammary protein stathmin as protumorigenic and suggest it may serve as a potential therapeutic target in breast cancer. SIGNIFICANCE: Stathmin expression is critical to maintain oriented cell division and apicobasal polarity in normal mammary glands and to establish a protumorigenic program that eventually sustains HER2-positive breast cancer formation in mice. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30478213     DOI: 10.1158/0008-5472.CAN-18-2488

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.

Authors:  Barbara Belletti; Guidalberto Manfioletti; Michela Sgubin; Silvia Pegoraro; Ilenia Pellarin; Gloria Ros; Riccardo Sgarra; Silvano Piazza; Gustavo Baldassarre
Journal:  Cell Death Dis       Date:  2022-05-03       Impact factor: 9.685

2.  HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.

Authors:  Junbiao Wang; Alessia Lamolinara; Laura Conti; Mara Giangrossi; Lishan Cui; Maria Beatrice Morelli; Consuelo Amantini; Maurizio Falconi; Caterina Bartolacci; Cristina Andreani; Fiorenza Orlando; Mauro Provinciali; Francesco Domenico Del Pizzo; Francesca Russo; Barbara Belletti; Federica Riccardo; Elisabetta Bolli; Elena Quaglino; Federica Cavallo; Augusto Amici; Manuela Iezzi; Cristina Marchini
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

3.  Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.

Authors:  Kohei Saeki; Gregory Chang; Noriko Kanaya; Xiwei Wu; Jinhui Wang; Lauren Bernal; Desiree Ha; Susan L Neuhausen; Shiuan Chen
Journal:  Commun Biol       Date:  2021-06-02

4.  miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.

Authors:  Francesca Citron; Ilenia Segatto; Lorena Musco; Ilenia Pellarin; Gian Luca Rampioni Vinciguerra; Giovanni Franchin; Giuseppe Fanetti; Francesco Miccichè; Vittorio Giacomarra; Valentina Lupato; Andrea Favero; Isabella Concina; Sanjana Srinivasan; Michele Avanzo; Isabella Castiglioni; Luigi Barzan; Sandro Sulfaro; Gianluigi Petrone; Andrea Viale; Giulio F Draetta; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  EMBO Mol Med       Date:  2021-06-01       Impact factor: 12.137

Review 5.  The molecular basis of mammary gland development and epithelial differentiation.

Authors:  Priscila Ferreira Slepicka; Amritha Varshini Hanasoge Somasundara; Camila O Dos Santos
Journal:  Semin Cell Dev Biol       Date:  2020-10-17       Impact factor: 7.499

6.  CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.

Authors:  Davide Viotto; Francesca Russo; Ilaria Anania; Ilenia Segatto; Gian Luca Rampioni Vinciguerra; Alessandra Dall'Acqua; Riccardo Bomben; Tiziana Perin; Martina Cusan; Monica Schiappacassi; Lorenzo Gerratana; Sara D'Andrea; Francesca Citron; Filippo Vit; Lorena Musco; Maria Chiara Mattevi; Giorgia Mungo; Milena S Nicoloso; Maura Sonego; Samuele Massarut; Roberto Sorio; Luigi Barzan; Giovanni Franchin; Giorgio Giorda; Emilio Lucia; Sandro Sulfaro; Vittorio Giacomarra; Jerry Polesel; Federica Toffolutti; Vincenzo Canzonieri; Fabio Puglisi; Valter Gattei; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  J Pathol       Date:  2020-12-04       Impact factor: 9.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.